Gerd Pluschke

10.8k citations

263 papers · 7.7k indexed · h-index 50

Impact in

Small Animals top 0.1%
- Infectious Diseases and Mycology
Microbiology top 0.2%
- Bacterial Infections and Vaccines

Papers in ⓘ

Small Animals 74
- Infectious Diseases and Mycology 71
Microbiology 41
- Bacterial Infections and Vaccines 40

Co-authors: Mark Achtman (14 shared papers)Katharina Röltgen (32 shared papers)Peter Overath (5 shared papers)Marie‐Thérèse Ruf (28 shared papers)Dorothy Yeboah‐Manu (28 shared papers)Marco Tamborrini (23 shared papers)Claudia Daubenberger (24 shared papers)Timothy P. Stinear (14 shared papers)
Journals: PLoS neglected tropical diseases (42 papers)Infection and Immunity (11 papers)PLoS ONE (9 papers)Immunogenetics (7 papers)Journal of Clinical Microbiology (7 papers)
Partner nations: Switzerland Ghana Germany

In The Last Decade

Gerd Pluschke

263 papers receiving 7.4k citations

Peers

Countries citing papers authored by Gerd Pluschke

Since Specialization

Citations

This map shows the geographic impact of Gerd Pluschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Pluschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Pluschke more than expected).

Fields of papers citing papers by Gerd Pluschke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Pluschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Pluschke. The network helps show where Gerd Pluschke may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerd Pluschke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerd Pluschke Line = papers co-authored together Gerd Pluschke links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 263 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A Role for Apical Membrane Antigen 1 during Invasion of Hepatocytes by Plasmodium falciparum Sporozoites Journal of Biological Chemistry ·Olivier Silvie, Jean‐François Franetich, Stéphanie Charrin, Markus S. Mueller, Anthony Siau, Myriam Bodescot, Eric Rubinstein, L Hannoun, Yupin Charoenvit, Clemens H. M. Kocken, Alan W. Thomas, Geert‐Jan van Gemert, Robert W. Sauerwein, Michael J. Blackman, Robin F. Anders, Gerd Pluschke, Dominique Mazier	2004	244
2	Buruli Ulcer (M. ulcerans Infection): New Insights, New Hope for Disease Control PLoS Medicine ·Paul D. R. Johnson, Timothy P. Stinear, Pamela L. C. Small, Gerd Pluschke, Richard W. Merritt, Françoise Portaels, Kris Huygen, John Hayman, Kingsley Asiedu	2005	185
3	An Outbreak of Serotype 1 Streptococcus pneumoniae Meningitis in Northern Ghana with Features That Are Characteristic of Neisseria meningitidis Meningitis Epidemics The Journal of Infectious Diseases ·Julia Leimkugel, Abudulai Adams Forgor, Sébastien Gagneux, Valentin Pflüger, Christian Flierl, Elizabeth Awine, Naegeli Martin, Jean‐Pierre Dangy, Thomas A. Smith, Abraham Hodgson, Gerd Pluschke	2005	160
4	Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proceedings of the National Academy of Sciences ·Gerd Pluschke, M. Vanek, Audrey E. Evans, Tanja Dittmar, P. Schmid, Peter Itin, Edward J. Filardo, R. Reisfeld	1996	145
5	Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing Infection and Immunity ·Gerd Pluschke, J Mayden, Mark Achtman, R. P. Levine	1983	142
6	Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1 Receptors Journal of Biological Chemistry ·Mark D. Bauer, Andrea Chicca, Marco Tamborrini, David Eisen, Raissa Lerner, Beat Lutz, Oliver Poetz, Gerd Pluschke, Jürg Gertsch	2012	138
7	Clonal Analysis of Descent and Virulence Among Selected Escherichia Coli Annual Review of Microbiology ·Mark Achtman, Gerd Pluschke	1986	137
8	On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer BMC Genomics ·Kenneth Doig, Kathryn E. Holt, Janet Fyfe, Caroline J. Lavender, Miriam Eddyani, Françoise Portaels, Dorothy Yeboah‐Manu, Gerd Pluschke, Torsten Seemann, Timothy P. Stinear	2012	109
9	Anti‐Carbohydrate Antibodies for the Detection of Anthrax Spores Angewandte Chemie International Edition ·Marco Tamborrini, Daniel B. Werz, Joachim Frey, Gerd Pluschke, Peter H. Seeberger	2006	105
10	Function of phospholipids in Escherichia coli. Characterization of a mutant deficient in cardiolipin synthesis. Journal of Biological Chemistry ·Gerd Pluschke, Yukinori Hirota, Peter Overath	1978	97
11	Prospective Study of a Serogroup XNeisseria meningitidisOutbreak in Northern Ghana The Journal of Infectious Diseases ·Sébastien Gagneux, Abraham Hodgson, Thomas A. Smith, Thierry Wirth, Ingrid Ehrhard, Giovanna Morelli, Blaise Genton, Fred Binka, Mark Achtman, Gerd Pluschke	2002	94
12	Synthetic GPI array to study antitoxic malaria response Nature Chemical Biology ·Faustin Kamena, Marco Tamborrini, Xinyu Liu, Yong-Uk Kwon, Fiona M. Thompson, Gerd Pluschke, Peter H. Seeberger	2008	92
13	Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types Infection and Immunity ·Gerd Pluschke, Andrew A. Mercer, Barica Kušećek, A Pohl, Mark Achtman	1983	87
14	Lipopolysaccharide, capsule, and fimbriae as virulence factors among O1, O7, O16, O18, or O75 and K1, K5, or K100 Escherichia coli Infection and Immunity ·Barica Kušećek, H Wloch, Andrew A. Mercer, V. Väisänen, Gerd Pluschke, T K Korhonen, Mark Achtman	1984	87
15	Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial PLoS ONE ·Fiona M. Thompson, David W. Porter, Shinji L. Okitsu, Nicole Westerfeld, Denise Vogel, Stephen Todryk, Ian Poulton, Simon Correa, Claire Hutchings, Tamara Berthoud, Susanna Dunachie, Laura Andrews, Jack Williams, Robert E. Sinden, Sarah C. Gilbert, Gerd Pluschke, Rinaldo Zurbriggen, Adrian V. S. Hill	2008	83
16	Clonal Waves of Neisseria Colonisation and Disease in the African Meningitis Belt: Eight- Year Longitudinal Study in Northern Ghana PLoS Medicine ·Julia Leimkugel, Abraham Hodgson, Abudulai Adams Forgor, Valentin Pflüger, Jean‐Pierre Dangy, Thomas A. Smith, Mark Achtman, Sébastien Gagneux, Gerd Pluschke	2007	77
17	Induction of Parasite Growth-Inhibitory Antibodies by a Virosomal Formulation of a Peptidomimetic of Loop I from Domain III of Plasmodium falciparum Apical Membrane Antigen 1 Infection and Immunity ·Markus S. Mueller, Annabelle Renard, Francesca Boato, Denise Vogel, Naegeli Martin, Rinaldo Zurbriggen, John A. Robinson, Gerd Pluschke	2003	77
18	Presence of Nonhemolytic Pneumolysin in Serotypes ofStreptococcus pneumoniaeAssociated with Disease Outbreaks The Journal of Infectious Diseases ·Johanna M. Jefferies, Calum Johnston, Lea‐Ann S. Kirkham, Graeme Cowan, Kirsty Ross, Andrew Smith, Stuart C. Clarke, Angela B. Brueggemann, Robert C. George, Bruno Pichon, Gerd Pluschke, Valentin Pflüger, Timothy J. Mitchell	2007	76
19	Structure of Escherichia coli membranes. Fatty acyl chain order parameters of inner and outer membranes and derived liposomes Biochemistry ·Hans Ulrich Gally, Gerd Pluschke, Peter Overath, Joachim Seelig	1980	73
20	Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21 Vaccine ·Oscar Kashala, Roberto Amador, María V Valero-Bernal, Alberto Moreno, Arnoldo Barbosa, Beatrice Nickel, Claudia Daubenberger, Fanny Guzmán, Gerd Pluschke, Manuel E. Patarroyo	2002	71

About Gerd Pluschke

Gerd Pluschke is a scholar working on Small Animals, Microbiology, Epidemiology, Endocrinology and Infectious Diseases, having authored 263 papers that have together received 7.7k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (108 papers), Infectious Diseases and Mycology (71 papers), Tuberculosis Research and Epidemiology (48 papers), Bacterial Infections and Vaccines (40 papers), Malaria Research and Control (39 papers), Mosquito-borne diseases and control (26 papers), Pneumonia and Respiratory Infections (25 papers) and vaccines and immunoinformatics approaches (21 papers). The work is most often cited by research in Small Animals (1.6k citations), Microbiology (1.0k citations), Endocrinology (582 citations), Epidemiology (3.7k citations) and Infectious Diseases (1.6k citations). Gerd Pluschke has collaborated with scholars based in Switzerland, Ghana and Germany. Frequent co-authors include Mark Achtman, Katharina Röltgen, Peter Overath, Marie‐Thérèse Ruf, Dorothy Yeboah‐Manu, Marco Tamborrini, Claudia Daubenberger, Timothy P. Stinear, Michael Käser and Jean‐Pierre Dangy. Their work appears in journals such as PLoS neglected tropical diseases, Infection and Immunity, PLoS ONE, Immunogenetics and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact